LTBR and inflammatory bowel disease: Overall, the consistent upregulation and context-specific localization of LIGHT, HVEM, and LTβR in sites of active intestinal inflammation across human disease and diverse colitis models underscores their central roles in orchestrating mucosal immune responses, leukocyte trafficking, and tissue injury in IBD.